Renal cell carcinoma: Recent developments in diagnostics and therapy

被引：3
作者：
Bedke J. [1 ]
Stenzl A. [1 ]
机构：
[1] Klinik für Urologie, Eberhard Karls Universität Tübingen, 72076 Tübingen
来源：
Der Urologe | 2010年 / 49卷 / Suppl 1期
关键词：
Adjuvant therapy; Diagnostic techniques; surgical; Nephrectomy; Renal cell carcinoma; Targeted therapy;
D O I：
10.1007/s00120-010-2378-5
中图分类号：
学科分类号：
摘要：
This review highlights new strategies in the treatment of renal cell carcinoma (RCC). The benign or malignant status of renal masses in preoperative imaging as well as the detection of metastases and their differentiation from secondary malignancies is discussed. For the prognostic stratification of RCC the TNM system has been adopted. Nephron-sparing (NS) techniques of laparoscopy, radiofrequency and cryoablation are critically compared and the newest results of robotic-assisted (DaVinci) NS surgery are given. The special question of cytoreductive surgery in primary metastatic disease and the question of adjuvant immunotherapy are raised. New medical treatment strategies including new substances, vaccines and the possibility of sequential therapy are discussed. © 2010 Springer-Verlag.
引用
收藏
页码：178 / 184
页数：6
相关论文
共 41 条
[1]  
Bedke J., Buse S., Pritsch M., Et al., Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: Possible prognostic differences, BJU Int, 103, pp. 1349-1354, (2009)
[2]  
Bedke J., Pritsch M., Buse S., Et al., Prognostic stratification of localized renal cell carcinoma by tumor size, J Urol, 180, pp. 62-67, (2008)
[3]  
Bedke J., Stenzl A., Immunologic mechanisms in RCC and allogeneic renal transplant rejection, Nat Rev Urol, 7, pp. 339-347
[4]  
Benway B.M., Bhayani S.B., Rogers C.G., Et al., Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: A multi-institutional analysis of perioperative outcomes, J Urol, 182, pp. 866-872, (2009)
[5]  
Benway B.M., Bhayani S.B., Rogers C.G., Et al., Robot-assisted partial nephrectomy: An International Experience, Eur Urol, 57, 5, pp. 815-820, (2010)
[6]  
Bird V.G., Kanagarajah P., Morillo G., Et al., Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): The role of 4 phase computerized tomography, World J Urol, 2010
[7]  
Chao D.H., Zisman A., Pantuck A.J., Et al., Changing concepts in the management of renal oncocytoma, Urology, 59, pp. 635-642, (2002)
[8]  
Di Lorenzo G., Carteni G., Autorino R., Et al., Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer, J Clin Oncol, 27, pp. 4469-4474, (2009)
[9]  
Doehn C., Merseburger A.S., Jocham D., Et al., Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?, Urologe A, 46, pp. 1371-1378, (2007)
[10]  
Feyerabend S., Gouttefangeas C., Stevanovic S., Et al., Adjuvant multipeptide vaccination in high-risk renal cell carcinoma, J Clin Oncol, 28, SUPPL., (2010)
12345